Mon, Sep 15, 2014, 1:37 AM EDT - U.S. Markets open in 7 hrs 53 mins


% | $
Quotes you view appear here for quick access.

Alnylam Pharmaceuticals, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • rnai_inv rnai_inv Apr 11, 2012 7:43 AM Flag

    Price drop.

    market + rsv results in the next months.

    Were you hoping for a quick trade?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • rnai_inv I am trying to establish a long here. But I have no illusion it will take time. But I am comforted to know Fidelity growth company and biotech funds added 1.3 to 1.4 Mil shares in February. They were not part of secondary and must have purchased in open market. Those two funds combined now control over 10% of overall shares. If they can buy in 11 to 13 $ range, it will be safer for me to buy at $10 I will add some if we get a deep below 10 next week.

      I also want to buy some for flipping into earnings report or perhaps beyond. If I remember correctly we should expect news before July? right?

      Have you looked at Alxn? I have a larger position there and intend to keep it.

      PS It seems this deep is industry wide in bio and healthcare as well. It is just profit taking and we should resume advances again. I think a Romney presidency will make the prospects for the group even better.

72.55+2.18(+3.10%)Sep 12 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
21Vianet Group, Inc.
NasdaqGSFri, Sep 12, 2014 4:00 PM EDT